Literature DB >> 23287097

Baseline TNFα operational capacity in fetal and maternal circulation prior to the onset of labor: "tuned for different purposes".

Jacobo L Santolaya1, Lindsay Kugler, Lissa Francois, Valeria Di Stefano, Gary A Ebert, Roman Wolf, Bingbing Wang, Joaquín Santolaya-Forgas.   

Abstract

OBJECTIVE: In this study, we sought to characterize the tumor necrosis factor α (TNFα) baseline operational capacity in mature fetuses and their mothers prior to the onset of labor.
MATERIALS AND METHODS: We used an experimental pregnant nonhuman primate model to measure the plasma concentration of TNFα, TNF transmembrane receptor I (TNFRI), and TNFRII with validated enzyme-linked immunosorbent assays. Coefficients of correlations between the maternal and the fetal values and the soluble TNFα, TNFRI, or TNFRII concentrations and ratios were calculated.
RESULTS: The TNFα/TNFRI ratio was 3 times lower in fetal circulation than in maternal circulation. No correlations were noted between the maternal and the fetal TNFα, TNFRI, or TNFRII plasma concentrations.
CONCLUSIONS: These findings suggest that the fetal and maternal baseline circulatory operational capacities of TNFα are independent of each other and tuned differently. This differential regulation of TNFα in fetal and maternal circulation at the end of pregnancy may be guided to protect the fetus from the systemic inflammatory response that is essential for the mechanisms of labor to proceed in the mother.

Entities:  

Keywords:  TNFα; TNFα receptors; baboon; fetal inflammatory response syndrome; sTNFRI; sTNFRII; sepsis; tumor necrosis factor α

Mesh:

Substances:

Year:  2013        PMID: 23287097      PMCID: PMC5933195          DOI: 10.1177/1933719112468953

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  56 in total

1.  Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants.

Authors:  Raymond W Redline; Deanne Wilson-Costello; Maureen Hack
Journal:  Pediatr Res       Date:  2002-11       Impact factor: 3.756

2.  Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2alpha) and indomethacin.

Authors:  U Ulug; S Goldman; I Ben-Shlomo; E Shalev
Journal:  Mol Hum Reprod       Date:  2001-12       Impact factor: 4.025

3.  Structure of human tumor necrosis factor alpha derived from recombinant DNA.

Authors:  J M Davis; M A Narachi; N K Alton; T Arakawa
Journal:  Biochemistry       Date:  1987-03-10       Impact factor: 3.162

4.  Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways.

Authors:  Iren Kossintseva; Susan Wong; Ed Johnstone; Larry Guilbert; David M Olson; B F Mitchell
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-09-20       Impact factor: 4.310

5.  Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspring.

Authors:  Suzan Lambin; Rita van Bree; Ignace Vergote; Johan Verhaeghe
Journal:  J Soc Gynecol Investig       Date:  2006-11-07

6.  Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.

Authors:  Joseph J Boyle; Peter L Weissberg; Martin R Bennett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-17       Impact factor: 8.311

7.  Screening for cytokine mRNA in human villous and extravillous trophoblasts using the reverse-transcriptase polymerase chain reaction (RT-PCR).

Authors:  A King; P P Jokhi; S K Smith; A M Sharkey; Y W Loke
Journal:  Cytokine       Date:  1995-05       Impact factor: 3.861

8.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.

Authors:  E Girardin; P Roux-Lombard; G E Grau; P Suter; H Gallati; J M Dayer
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation.

Authors:  H L Chen; Y P Yang; X L Hu; K K Yelavarthi; J L Fishback; J S Hunt
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.